High glycosylated hemoglobin level as a risk factor of latent tuberculosis infection in patients with uncomplicated type 2 diabetes mellitus

Main Article Content

Yunita Arliny
https://orcid.org/0000-0003-1950-4025
Dewi Behtri Yanifitri
Diennisa Mursalin

Abstract

Background
Diabetes mellitus (DM) is known to increase the risk of infection including tuberculosis (TB). Some studies also showed that 2-15% of latent TB infection (LTBI) will progress to active TB. This study aimed to obtain the prevalence of LTBI and to determine the risk factors of LTBI in patients with type 2 diabetes mellitus (T2DM).


Methods
This was a cross-sectional study on 242 adult T2DM patients. For LTBI screening we performed the interferon gamma release assay (IGRA) (Quantiferon TB Gold Plus test) and for confirmation of active TB (pulmonary TB) we performed GeneXpert MTB/Rif sputum examination and chest X-ray. Glycosylated hemoglobin (HbA1c) levels, smoking history and BCG scar were collected. Multivariate logistic regression was used to analyze the data.


Results
Positive IGRA results were found in 99 of 242 uncomplicated T2DM patients while LTBI was found in 82 patients (33.8%). There were significant differences between T2DM patients with latent TB and T2DM patients without infection in HbA1c and specific IFN-ã levels (TB1 minus nil and TB2 minus nil), i.e. 8.5% and 7.6%, 2.5 IU/mL and 0.06 IU/mL, and 2.6 IU/mL and 0.08 IU/mL, respectively. Multivariate analysis showed that the risk factors for LTBI in T2DM patients were smoking history, HbA1c >7%, and no BCG scar.


Conclusions
Because LTBI is prevalent in T2DM, it is important to screen for it in T2DM patients due to the risk of developing severe active TB. Absence of a BCG scar and high HbA1c levels are strong predictors of LTBI in T2DM patients.

Article Details

How to Cite
Arliny, Y., Yanifitri, D. B. ., & Mursalin, D. . (2022). High glycosylated hemoglobin level as a risk factor of latent tuberculosis infection in patients with uncomplicated type 2 diabetes mellitus. Universa Medicina, 41(1), 47–55. https://doi.org/10.18051/UnivMed.2022.v41.47-55
Section
Original Articles

References

Kementrian Kesehatan Republik Indonesia. The Republic of Indonesia joint external monitoring mission for tuberculosis; 2020.

Salgame P, Geadas C, Collins L, Jones-López E, Ellner JJ. Latent tuberculosis infection - revisiting and revising concepts. Tuberculosis (Edinb) 2015;95:373–84. doi:10.1016/j.tube.2015.04.003.

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008;5:1091–101. doi: 10.1371/journal.pmed.0050152.

Kementerian Kesehatan Republik Indonesia. Indonesia National TB Program. Current status of integrated community based TB service delivery and the Global Fund work plan to find missing TB cases; 2018.

Ping PA, Zakaria R, Islam MA, et al. Prevalence and risk factors of latent tuberculosis infection (LTBI) in patients with type 2 diabetes mellitus (T2DM). Int J Environ Res Public Health 2021;18:305. doi: 10.3390/ijerph18010305.

Agha MA, Yousif M, Shehab-Eldin W, El-Helbawy NG, Moustafa RG, Sweed EM. Latent tuberculosis infection among patients with type 2 diabetes mellitus. Egypt J Chest Dis Tuberc 2020;69:277–83. DOI: 10.4103/ejcdt.ejcdt_85_19.

Lee MR, Huang YP, Kuo YT, et al. Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis. Clin Infect Dis 2017;64:719–27. doi: 10.1093/cid/ciw836.

van Crevel R, Dockrell HM; TANDEM Consortium. TANDEM: understanding diabetes and tuberculosis. Lancet Diabetes Endocrinol 2014;2:270-72. doi: 10.1016/S2213-8587(14)70011-7.

Koesoemadinata RC, McAllister SM, Soetedjo NNM, et al. Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia. Trans R Soc Trop Med Hyg 2017;111:81–9. doi:10.1093/trstmh/trx015.

Leow MKS, Dalan R, Chee CBE, et al. Latent tuberculosis in patients with diabetes mellitus: prevalence, progression and public health implications. Exp Clin Endocrinol Diabetes 2014;122:528–32. doi: 10.1055/s-0034-1377044.

Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: a systematic review. PLoS One 2017;12:e0175925. doi: 10.1371/journal.pone.0175925.

Zheng C, Hu M, Gao F. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Glob Health Action 2017;10:1264702. doi: 10.1080/16549716.2016.1264702.

Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol. 2012;12:581–91.

Wagnew F, Eshetie S, Alebel A, Dessie G, Tesema C, Abajobir AA. Meta-analysis of the prevalence of tuberculosis in diabetic patients and its association with cigarette smoking in African and Asian countries. BMC Res Notes 2018;11:1–7. https://doi.org/10.1186/s13104-018-3390-x.

Zhang H, Xin H, Li X, et al. A dose-response relationship of smoking with tuberculosis infection: a cross-sectional study among 21008 rural residents in China. PLoS One 2017;12: e0175183. doi:10.1371/journal.pone.0175183 .

Bai KJ, Lee JJ, Chien ST, Suk CW, Chiang CY. The influence of smoking on pulmonary tuberculosis in diabetic and non-diabetic patients. PLoS One 2016;11:e0156677. doi: 10.1371/journal.pone. 0156677.

Ruder K, Anthony R, Ogden A, Guthrie G, editors. American Diabetes Association Complete guide to diabetes. 5th ed. Alexandria, Virginia : American Diabetes Association;2011.

Martínez-Aguilar G, Serrano CJ, Castañeda-Delgado JE, et al. Associated risk factors for latent tuberculosis infection in subjects with diabetes. Arch Med Res 2015;46:221–7. doi: 10.1016/j.arcmed.2015.03.009.

Chen Z, Liu Q, Song R, et al. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocr Disord 2021;21. https://doi.org/10.1186/s12902-021-00779-6.

Ye S, Ruan P, Yong J, Shen H, Liao Z, Dong X. The impact of HbA1c level of type 2 diabetics on the structure of haemoglobin. Sci Rep 2016;6:33352. doi: 10.1038/srep33352.

Abebe G, Bonsa Z, Kebede W. Treatment outcomes and associated factors in tuberculosis patients at Jimma University Medical Center: a 5-year retrospective study. Int J Mycobacteriol 2019;8:35-41. doi: 10.4103/ijmy.ijmy_177_18.

Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI. Reduced association of mycobacteria with monocytes from diabetes patients with poor glucose control. Tuberculosis (Edinb) 2013;93:192-7. doi:10.1016/j.tube.2012.10.003.

Lin CH, Kuo SC, Hsieh MC, et al. Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open 2019;9:1–8. doi: 10.1136/bmjopen-2019-029948.

Chen C, Zhu T, Wang Z, et al. High latent TB infection rate and associated risk factors in the Eastern China of low TB incidence. PLoS One 2015;109. doi.: 10.1371/journal.pone.0141511.

Trollfors B, Sigurdsson V, Dahlgren-Aronsson A. Prevalence of latent TB and effectiveness of BCG vaccination against latent tuberculosis: an observational study. Int J Infect Dis 2021;109:279-82. https://doi.org/10.1016/j.ijid.2021.06.045.